Form 4: Arcutis Biotherapeutics Director Sells Shares
Insider Transaction (Form 4)
Howard G. Welgus, a Director of Arcutis Biotherapeutics, Inc., sold 4,728 shares of common stock on October 15, 2026 for $26.93 per share.
Summary
- Option exercise/conversion: acquired 822 Common Stock at $6.52 ($5,361) on October 15, 2026; holds 36,663 after (Direct).
- Option exercise/conversion: acquired 1,018 Common Stock at $7.51 ($7,645) on October 15, 2026; holds 37,681 after (Direct).
- Option exercise/conversion: acquired 2,254 Common Stock at $8.63 ($19,452) on October 15, 2026; holds 39,935 after (Direct).
- Open-market sale: disposed of 4,728 Common Stock at $26.93 ($127,325) on October 15, 2026; holds 35,207 after (Direct).
- Option exercise/conversion: disposed of 822 Stock Option (right to buy) on October 15, 2026; holds 5,752 after (Direct).
- Option exercise/conversion: disposed of 1,018 Stock Option (right to buy) on October 15, 2026; holds 7,126 after (Direct).
- Option exercise/conversion: disposed of 2,254 Stock Option (right to buy) on October 15, 2026; holds 15,778 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $127,325 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Howard G. Welgus — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Option exercise/conversion | Common Stock | 822 | $7 | $5.4K | 36,663 |
| 2026-10-15 | Option exercise/conversion | Common Stock | 1,018 | $8 | $7.6K | 37,681 |
| 2026-10-15 | Option exercise/conversion | Common Stock | 2,254 | $9 | $19.5K | 39,935 |
| 2026-10-15 | Open-market sale | Common Stock | 4,728 | $27 | $127.3K | 35,207 |
| 2026-10-15 | Option exercise/conversion | Stock Option (right to buy) | 822 | — | — | 5,752 |
| 2026-10-15 | Option exercise/conversion | Stock Option (right to buy) | 1,018 | — | — | 7,126 |
| 2026-10-15 | Option exercise/conversion | Stock Option (right to buy) | 2,254 | — | — | 15,778 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Option exercise/conversion (822 shares) |
| 2026-10-15 | Option exercise/conversion (1,018 shares) |
| 2026-10-15 | Option exercise/conversion (2,254 shares) |
| 2026-10-15 | Open-market sale (4,728 shares) |
| 2026-10-15 | Option exercise/conversion (822 shares) |
| 2026-10-15 | Option exercise/conversion (1,018 shares) |
| 2026-10-15 | Option exercise/conversion (2,254 shares) |
Keywords
insider transaction, Form 4, ARQT, Arcutis Biotherapeutics, Inc., bearish, Howard G. Welgus
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.